z-logo
Premium
Tofacitinib: a new oral Janus kinase inhibitor for psoriasis
Author(s) -
Fleming P.
Publication year - 2019
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.17323
Subject(s) - tofacitinib , janus kinase inhibitor , psoriasis , janus kinase , dermatology , medicine , janus , plaque psoriasis , materials science , rheumatoid arthritis , cytokine , nanotechnology
Linked Article:   Strober et al. Br J Dermatol 2019; 180 :67–75.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here